世界のヒト用オルガノイド市場2020年-2027年:製品別(膵臓、腎臓、肺、GIT、肝臓モデル)、ユーザビリティ別、用途別、エンドユーザー別、地域別

【英語タイトル】Global Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usability (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), End-user (Pharma-Biotech, CROs, Academia) and Regional Forecasts 2020-2027

Bizwit Research & Consultingが出版した調査資料(BZW21JA03)・商品コード:BZW21JA03
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2020年12月20日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、英国、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC
・産業分野:医療・ライフサイエンス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Researchの本調査レポートは、世界のヒト用オルガノイド市場について、調査・分析したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、市場環境分析、製品別(膵臓、腎臓、肺、GIT、肝臓モデル)分析、用途別(毒性、病理、パーソナライズ、再生医療)分析、エンドユーザー別(カスタマイズ、既製)分析、競争状況、調査プロセスなどを掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場環境分析
・世界のヒト用オルガノイド市場規模:製品別(膵臓、腎臓、肺、GIT、肝臓モデル)
・世界のヒト用オルガノイド市場規模:用途別(毒性、病理、パーソナライズ、再生医療)
・世界のヒト用オルガノイド市場規模:エンドユーザー別(カスタマイズ、既製)
・競争状況
・調査プロセス

Global Human Organoids Market is valued approximately at USD 723.40 million in 2019 and is anticipated to grow with a healthy growth rate of more than 17.5 % over the forecast period 2020-2027. Organoids are microscopic, self-organized tissue cultures taken from stem cells. Such cultures can be collected to duplicate much of the intricacy of an organ, or to express preferred aspects of it like producing only convinced types of cells. This market is expected to grow significantly due to the rising demand in transplants. Earlier its was challenging to provide a transplant as the organs such as kidney, liver, and heart have very few minutes to function properly due to lack of oxygen after a person is declared brain dead. Now with much efficient supply chain and transportation it has become much more convenient. Constant evolution in the genetic codes has made it troublesome to use animals for testing drugs and due to the stringent rules enforced by the government to contain animal cruelty has boosted the human organoid market. In 2019, Organovo partnered with MCRI and Leiden University Medical Center to develop stem cell-based bio printed tissue treatment for kidney diseases. However, the market lacks the skilled researchers and scientists needed to bridge the gap between mankind and technology owing to the complications involved in this procedure. Incorporation of cultured cells in a new biological environment can be affected due to various technical challenges.

The regional analysis of global Human Organoids Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising demand for new and improved drugs. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the need to develop cost effective drugs would create lucrative growth prospects for the Human Organoids Market across Asia-Pacific region.

Major market player included in this report are:

BioIVT (US)
Thermo Fisher Scientific (US)
ZenBio (US)
Corning (US)
Organovo (US)
Cyprid (France)
Biopredic International (France)
CELLINK (Sweden)
Emulate (US)
Hµrel Corporation (US)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and
sub-segment of the market are explained below:
By Products:
Pancreas
Kidney
Lung
GIT
Liver Models

By Usability:
Customized
Ready-To-Use

By Application:
Toxicity
Pathology
Personalized
Regenerative Medicine

By End-User:
Pharma-Biotech
CROs
Academia

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Human Organoids Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Human Organoids Market, by Region, 2018-2027 (USD Million)
1.2.2. Human Organoids Market, by Product, 2018-2027 (USD Million)
1.2.3. Human Organoids Market, by Application, 2018-2027 (USD Million)
1.2.4. Human Organoids Market, by End-User, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Organoids Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Processing Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Organoids Market Dynamics
3.1. Human Organoids Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Human Organoids Market Processing Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Human Organoids Market, by Product
5.1. Market Snapshot
5.2. Global Human Organoids Market by Type, Product – Potential Analysis
5.3. Global Human Organoids Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. Human Organoids Market, Sub Segment Analysis
5.4.1. Pancreas
5.4.2. Kidney
5.4.3. Lung
5.4.4. GIT
5.4.5. Liver Models
Chapter 6. Global Human Organoids Market, by Application
6.1. Market Snapshot
6.2. Global Human Organoids Market by Processing, Application – Potential Analysis
6.3. Global Human Organoids Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. Human Organoids Market, Sub Segment Analysis
6.4.1. Toxicity
6.4.2. Pathology
6.4.3. Personalized
6.4.4. Regenerative Medicine
Chapter 7. Global Human Organoids Market, by Use-End
7.1. Market Snapshot
7.2. Global Human Organoids Market by Processing, User-End – Potential Analysis
7.3. Global Human Organoids Market Estimates & Forecasts by User-End 2017-2027 (USD Million)
7.4. Human Organoids Market, Sub Segment Analysis
7.4.1. Customized
7.4.2. Ready-To-Use

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. BioIVT (US)
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Thermo Fisher Scientific (US)
8.2.3. ZenBio (US)
8.2.4. Corning (US)
8.2.5. Organovo (US)
8.2.6. Cyprid (France)
8.2.7. Biopredic International (France)
8.2.8. CELLINK (Sweden)
8.2.9. Emulate (US)
9.2.10Hµrel Corporation (US)
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Human Organoids market, report scope
TABLE 2. Global Human Organoids market estimates & forecasts by Region 2017-2027 (USD Million)
TABLE 3. Global Human Organoids market estimates & forecasts by Products 2017-2027 (USD Million)
TABLE 4. Global Human Organoids market estimates & forecasts by Application 2017-2027 (USD Million)
TABLE 5. Global Human Organoids market estimates & forecasts by End-User 2017-2027 (USD Million)
TABLE 6. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 7. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 8. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 9. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 10. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 11. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 12. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 13. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 14. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 15. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 16. U.S. Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 17. U.S. Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 18. U.S. Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 19. Canada Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 20. Canada Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 21. Canada Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 22. UK Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 23. UK Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 24. UK Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 25. Germany Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 26. Germany Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 27. Germany Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 28. RoE Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 29. RoE Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 30. RoE Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 31. China Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 32. China Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 33. China Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 34. India Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 35. India Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 36. India Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 37. Japan Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 38. Japan Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 39. Japan Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 40. RoAPAC Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 41. RoAPAC Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 42. RoAPAC Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 43. Brazil Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 44. Brazil Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 45. Brazil Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 46. Mexico Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 47. Mexico Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 48. Mexico Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 49. RoLA Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 50. RoLA Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 51. RoLA Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 52. Row Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
TABLE 53. Row Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 54. Row Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Human Organoids market
TABLE 56. List of primary sources, used in the study of global Human Organoids market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

List of figures
FIG 1. Global Human Organoids market, research methodology
FIG 2. Global Human Organoids market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Human Organoids market, key trends 2019
FIG 5. Global Human Organoids market, growth prospects 2020-2027
FIG 6. Global Human Organoids market, porters 5 force model
FIG 7. Global Human Organoids market, pest analysis
FIG 8. Global Human Organoids market, value chain analysis
FIG 9. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
FIG 10. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
FIG 11. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
FIG 12. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
FIG 13. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
FIG 14. Global Human Organoids market, regional snapshot 2017 & 2027
FIG 15. North America Human Organoids market 2017 & 2027 (USD Million)
FIG 16. Europe Human Organoids market 2017 & 2027 (USD Million)
FIG 17. Asia pacific Human Organoids market 2017 & 2027 (USD Million)
FIG 18. Latin America Human Organoids market 2017 & 2027 (USD Million)
FIG 19. Global Human Organoids market, company market share analysis (2019)

★調査レポート[世界のヒト用オルガノイド市場2020年-2027年:製品別(膵臓、腎臓、肺、GIT、肝臓モデル)、ユーザビリティ別、用途別、エンドユーザー別、地域別] (コード:BZW21JA03)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒト用オルガノイド市場2020年-2027年:製品別(膵臓、腎臓、肺、GIT、肝臓モデル)、ユーザビリティ別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆